Atezolizumab-related encephalitis in the intensive care unit: Case report and review of the literature

Atezolizumab is a monoclonal antibody that targets programmed death ligand-1. Treatments with this drug may cause immune-related adverse events by creating an exaggerated inflammatory response. The most common side effects are fatigue, rash, and gastrointestinal symptoms. Cases of central nervous sy...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:SAGE Open Med Case Rep
Asıl Yazarlar: Laserna, Andrés, Tummala, Sudhakar, Patel, Neel, El Hamouda, Diaa Eldin Mohamed, Gutiérrez, Cristina
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2018
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6088478/
https://ncbi.nlm.nih.gov/pubmed/30116528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050313X18792422
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller